Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2008-09-25 13:33:53 UTC |
---|
Update Date | 2022-11-30 19:03:54 UTC |
---|
HMDB ID | HMDB0010577 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | PG(16:0/18:3(9Z,12Z,15Z)) |
---|
Description | PG(16:0/18:3(9Z,12Z,15Z)) is a phosphatidylglycerol or glycerophospholipid (PG or GP). It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(16:0/18:3(9Z,12Z,15Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of a-linolenic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Phosphatidylglycerol is present at a level of 1-2% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant at up to 11% of the total. It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for diphosphatidylglycerol (cardiolipin). Phosphatidylglycerol is formed from phosphatidic acid by a sequence of enzymatic reactions that proceeds via the intermediate, cytidine diphosphate diacylglycerol (CDP-diacylglycerol). Bioynthesis proceeds by condensation of phosphatidic acid and cytidine triphosphate with elimination of pyrophosphate via the action of phosphatidate cytidyltransferase (or CDP-synthase). CDP-diacylglycerol then reacts with glycerol-3-phosphate via phosphatidylglycerophosphate synthase to form 3-sn-phosphatidyl-1'-sn-glycerol 3'-phosphoric acid, with the release of cytidine monophosphate (CMP). Finally, phosphatidylglycerol is formed by the action of specific phosphatases. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PGs have a net charge of -1 at physiological pH and are found in high concentration in mitochondrial membranes and as components of pulmonary surfactant. PG also serves as a precursor for the synthesis of cardiolipin. PG is synthesized from CDP-diacylglycerol and glycerol-3-phosphate. |
---|
Structure | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC InChI=1S/C40H73O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h5,7,11,13,17-18,37-38,41-42H,3-4,6,8-10,12,14-16,19-36H2,1-2H3,(H,45,46)/b7-5-,13-11-,18-17-/t37-,38+/m0/s1 |
---|
Synonyms | Value | Source |
---|
1-Hexadecanoyl-2-(9Z,12Z,15Z-octadeatrienoyl)-sn-glycero-3-phospho-(1'-glycerol) | HMDB | 1-Palmitoyl-2-a-linolenoyl-sn-glycero-3-phosphoglycerol | HMDB | 1-Palmitoyl-2-alpha-linolenoyl-sn-glycero-3-phosphoglycerol | HMDB | GPG(16:0/18:3) | HMDB | GPG(16:0/18:3N3) | HMDB | GPG(16:0/18:3W3) | HMDB | GPG(34:3) | HMDB | PG(16:0/18:3) | HMDB | PG(16:0/18:3N3) | HMDB | PG(16:0/18:3W3) | HMDB | PG(34:3) | HMDB | Phosphatidylglycerol(16:0/18:3) | HMDB | Phosphatidylglycerol(16:0/18:3n3) | HMDB | Phosphatidylglycerol(16:0/18:3W3) | HMDB | Phosphatidylglycerol(34:3) | HMDB | 1-Hexadecanoyl-2-(9Z,12Z,15Z-octadeatrienoyl)-sn-glycero-3-phosphoglycerol | HMDB | PG(16:0/18:3(9Z,12Z,15Z)) | Lipid Annotator |
|
---|
Chemical Formula | C40H73O10P |
---|
Average Molecular Weight | 744.9754 |
---|
Monoisotopic Molecular Weight | 744.494135068 |
---|
IUPAC Name | [(2S)-2,3-dihydroxypropoxy][(2R)-3-(hexadecanoyloxy)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxy]phosphinic acid |
---|
Traditional Name | (2S)-2,3-dihydroxypropoxy(2R)-3-(hexadecanoyloxy)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxyphosphinic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC |
---|
InChI Identifier | InChI=1S/C40H73O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h5,7,11,13,17-18,37-38,41-42H,3-4,6,8-10,12,14-16,19-36H2,1-2H3,(H,45,46)/b7-5-,13-11-,18-17-/t37-,38+/m0/s1 |
---|
InChI Key | MLANVLMRGHBUJH-FTZNWAQRSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phosphatidylglycerols. These are glycerophosphoglycerols in which two fatty acids are bonded to the 1-glycerol moiety through ester linkages. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Glycerophospholipids |
---|
Sub Class | Glycerophosphoglycerols |
---|
Direct Parent | Phosphatidylglycerols |
---|
Alternative Parents | |
---|
Substituents | - 1,2-diacylglycerophosphoglycerol
- Fatty acid ester
- Dialkyl phosphate
- Dicarboxylic acid or derivatives
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Fatty acyl
- 1,2-diol
- Carboxylic acid ester
- Secondary alcohol
- Carboxylic acid derivative
- Organic oxide
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Primary alcohol
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0081175)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:0) (PathBank: SMP0081176)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:1(11Z)) (PathBank: SMP0081177)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:1(13Z)) (PathBank: SMP0081178)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:0) (PathBank: SMP0081179)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:1(13Z)) (PathBank: SMP0081180)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/20:0) (PathBank: SMP0081181)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/20:1(11Z)) (PathBank: SMP0081182)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/20:1(13Z)) (PathBank: SMP0081183)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/22:0) (PathBank: SMP0081184)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/22:1(13Z)) (PathBank: SMP0081185)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:1(11Z)/20:1(11Z)) (PathBank: SMP0081186)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:1(11Z)/20:1(13Z)) (PathBank: SMP0081187)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:1(11Z)/22:0) (PathBank: SMP0081188)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:1(11Z)/22:1(13Z)) (PathBank: SMP0081189)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:1(13Z)/20:1(13Z)) (PathBank: SMP0081190)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:1(13Z)/22:0) (PathBank: SMP0081191)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:1(13Z)/22:1(13Z)) (PathBank: SMP0081192)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/22:0/22:0) (PathBank: SMP0081193)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/22:0/22:1(13Z)) (PathBank: SMP0081194)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0081195)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083836)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083837)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083838)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083839)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083840)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0083842)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0083843)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083844)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083845)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083846)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083847)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083848)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083849)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083850)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083851)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083852)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083853)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083854)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083855)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083856)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083857)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083858)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083859)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083860)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083861)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0098609)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098610)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0098615)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0098616)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/22:0) (PathBank: SMP0098618)
- Cardiolipin Biosynthesis CL(16:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)) (PathBank: SMP0098619)
|
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) 10V, Positive-QTOF | splash10-004s-3090510500-a758cee78620b4e3fd3e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) 20V, Positive-QTOF | splash10-01ti-4191311100-ca4f438e248fb0bd9e2f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) 40V, Positive-QTOF | splash10-08i0-7193120000-b440646dda2c17947a7c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) 10V, Negative-QTOF | splash10-0a70-0190200200-01a990e389c182e0257e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) 20V, Negative-QTOF | splash10-0a6r-5290100000-1dbde8f09ed3280134b2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) 40V, Negative-QTOF | splash10-004i-9020000000-78367e2fabec43074a99 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) 10V, Negative-QTOF | splash10-0006-0000000900-630159f35098b390880d | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) 20V, Negative-QTOF | splash10-0a6x-0090300400-cf59f3f5d02048a5f62b | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(16:0/18:3(9Z,12Z,15Z)) 40V, Negative-QTOF | splash10-054o-0190300400-30216bcf4ede883f57ab | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|